Zim Vie Inc. ZIMV
We take great care to ensure that the data presented and summarized in this overview for ZimVie Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding ZIMV
View all-
Camber Capital Management LP Boston, MA2.73MShares$32.2 Million0.88% of portfolio
-
Eversept Partners, LP New York, NY2.07MShares$24.5 Million2.94% of portfolio
-
Black Rock Inc. New York, NY1.82MShares$21.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.78MShares$21.1 Million0.0% of portfolio
-
J. Goldman & CO LP New York, NY1.43MShares$16.8 Million0.57% of portfolio
-
Neuberger Berman Group LLC New York, NY1.31MShares$15.5 Million0.02% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.25MShares$14.8 Million10.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.24MShares$14.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY772KShares$9.12 Million0.0% of portfolio
-
Kent Lake Pr LLC Anasco, PR700KShares$8.27 Million4.13% of portfolio
Latest Institutional Activity in ZIMV
Top Purchases
Top Sells
About ZIMV
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.
Insider Transactions at ZIMV
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 10
2025
|
Vafa Jamali Director |
SELL
Payment of exercise price or tax liability
|
Direct |
9,107
-2.55%
|
$109,284
$12.2 P/Share
|
Mar 10
2025
|
Vafa Jamali Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,815
+5.51%
|
-
|
Mar 10
2025
|
Heather Kidwell Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
759
-0.97%
|
$9,108
$12.2 P/Share
|
Mar 10
2025
|
Heather Kidwell Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,775
+3.41%
|
-
|
Mar 10
2025
|
Indraneel Kanaglekar Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,014
-1.85%
|
$12,168
$12.2 P/Share
|
Mar 10
2025
|
Indraneel Kanaglekar Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,163
+7.05%
|
-
|
Mar 10
2025
|
Richard Heppenstall Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,690
-1.46%
|
$20,280
$12.2 P/Share
|
Mar 10
2025
|
Richard Heppenstall Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,938
+5.65%
|
-
|
Mar 10
2025
|
Sandra Schneider Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
875
-2.63%
|
$10,500
$12.2 P/Share
|
Mar 10
2025
|
Sandra Schneider Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,590
+9.74%
|
-
|
Mar 07
2025
|
Vafa Jamali Director |
SELL
Payment of exercise price or tax liability
|
Direct |
29,832
-8.15%
|
$357,984
$12.78 P/Share
|
Mar 07
2025
|
Vafa Jamali Director |
BUY
Exercise of conversion of derivative security
|
Direct |
90,065
+19.74%
|
-
|
Mar 07
2025
|
Heather Kidwell Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,508
-5.61%
|
$54,096
$12.78 P/Share
|
Mar 07
2025
|
Heather Kidwell Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,170
+15.89%
|
-
|
Mar 07
2025
|
Indraneel Kanaglekar Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,177
-5.9%
|
$38,124
$12.78 P/Share
|
Mar 07
2025
|
Indraneel Kanaglekar Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,377
+17.43%
|
-
|
Mar 07
2025
|
Richard Heppenstall Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,339
-5.5%
|
$76,068
$12.78 P/Share
|
Mar 07
2025
|
Richard Heppenstall Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,650
+17.61%
|
-
|
Mar 07
2025
|
Sandra Schneider Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,753
-5.58%
|
$21,036
$12.78 P/Share
|
Mar 07
2025
|
Sandra Schneider Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,542
+17.24%
|
-
|
Last 12 Months Summary
Exercise of conversion of derivative security | 312K shares |
---|
Payment of exercise price or tax liability | 109K shares |
---|---|
Open market or private sale | 525K shares |